Nathan SD - Search Results

1

Pulmonary matrix-derived hydrogels from patients with idiopathic pulmonary fibrosis induce a proinflammatory state in lung fibroblasts in vitro.

Fernandez Davila JG, Singh AK, Moore DW, Kim J, Khan JA, Lemma M, King CS, Nathan SD, Rodriguez LR, Grant GM, Moran JL. Fernandez Davila JG, et al. Among authors: nathan sd. Mol Biol Cell. 2024 Aug 1;35(8):ar114. doi: 10.1091/mbc.E23-11-0428. Epub 2024 Jul 10. Mol Biol Cell. 2024. PMID: 38985514 Free PMC article.

2

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.

Chhina MK, Nargues W, Grant GM, Nathan SD. Chhina MK, et al. Among authors: nathan sd. Future Cardiol. 2010 Jan;6(1):19-35. doi: 10.2217/fca.09.54. Future Cardiol. 2010. PMID: 20014985 Review.

3

Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis.

Emblom-Callahan MC, Chhina MK, Shlobin OA, Ahmad S, Reese ES, Iyer EP, Cox DN, Brenner R, Burton NA, Grant GM, Nathan SD. Emblom-Callahan MC, et al. Among authors: nathan sd. Genomics. 2010 Sep;96(3):134-45. doi: 10.1016/j.ygeno.2010.04.005. Epub 2010 May 6. Genomics. 2010. PMID: 20451601 Free article.

4

Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis.

Chhina M, Shlobin OA, Grant G, Nathan SD. Chhina M, et al. Among authors: nathan sd. Expert Rev Respir Med. 2008 Aug;2(4):419-31. doi: 10.1586/17476348.2.4.419. Expert Rev Respir Med. 2008. PMID: 20477206

5

Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.

Shlobin OA, Brown AW, Weir N, Ahmad S, Lemma M, Nathan SD. Shlobin OA, et al. Among authors: nathan sd. Lung. 2012 Oct;190(5):573-8. doi: 10.1007/s00408-012-9408-6. Epub 2012 Jul 15. Lung. 2012. PMID: 22797830

6

Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.

King C, Nathan SD. King C, et al. Among authors: nathan sd. Curr Opin Pulm Med. 2013 Sep;19(5):466-73. doi: 10.1097/MCP.0b013e328363f460. Curr Opin Pulm Med. 2013. PMID: 23912191 Review.

7

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?

Nathan SD, King CS. Nathan SD, et al. Drug Des Devel Ther. 2014 Jul 2;8:875-85. doi: 10.2147/DDDT.S64907. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25061279 Free PMC article. Review.

8

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD. Shin S, et al. Among authors: nathan sd. Respir Med. 2014 Nov;108(11):1626-32. doi: 10.1016/j.rmed.2014.08.009. Epub 2014 Sep 2. Respir Med. 2014. PMID: 25225149 Free article.

9

Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.

Kirillov V, Siler JT, Ramadass M, Ge L, Davis J, Grant G, Nathan SD, Jarai G, Trujillo G. Kirillov V, et al. Among authors: nathan sd. Am J Pathol. 2015 Apr;185(4):943-57. doi: 10.1016/j.ajpath.2014.12.011. Epub 2015 Feb 7. Am J Pathol. 2015. PMID: 25660181 Free article.

10

Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosis.

King CS, Nathan SD. King CS, et al. Among authors: nathan sd. Curr Opin Pulm Med. 2015 Sep;21(5):479-89. doi: 10.1097/MCP.0000000000000190. Curr Opin Pulm Med. 2015. PMID: 26164298 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters